From: Olmsted syndrome: exploration of the immunological phenotype
Subset | Defining surface markers | Patient (%) | Healthy volunteers (%) | Â |
---|---|---|---|---|
 |  |  | Mean (SD) | Median (min-max) |
T cells | CD3+ | 25.0 | 21.7 (10.7) | 20.2 (8.48-41.6) |
B cells | CD19+ | 25.7 | 28.9 (11.5) | 26.5 (16.9-55.1) |
γδ T cells | γδ TCR+ | 0.25 | 0.23 (0.21) | 0.15 (0.04-0.72) |
iNKT cells | CD3+Vα24Jα18+ | 0.49 | 0.52 (0.25) | 0.55 (0.09-0.89) |
NKT cells | CD3+CD56+ | 2.49 | 10.2 (4.91) | 9.35 (4.15-16.8) |
NK cells | CD3-CD19-CD14-CD11c-CD56+ | 22.0 | 21.2 (10.1) | 18.2 (9.17-40.8 |
Dendritic cells | CD3-CD19-CD14-CD56- | 6.67 | 6.66 (2.76) | 6.21 (2.96-11.4) |
 →mDC | CD11c+HLA-DR+ | 35.5 | 41.4 (6.17) | 42.2 (31.8-55.4) |
 →pDC | CD11c-CD123+ | 21.3 | 16.8 (10.9) | 19.9 (3.88-39.25) |